ICIs Result in Increased Rates of High-Grade irAEs for Older Patients With Breast Cancer
Dr Grinshpun on Ultra-Sensitive ctDNA Detection in HR+ Early Breast Cancer
Dr Mayer on Niraparib Plus Dostarlimab in ER+ BRCA/PALB2-Mutated Breast Cancer
Recurrence-Free Interval Is Longer With Low ctDNA Levels at Baseline in TNBC
2 Commerce Drive
Cranbury, NJ 08512